ChromoTek

acquiredunknown
unknown
Stage
2010
Founded
1
Investors

About

ChromoTek develops and manufactures high-quality research reagents, primarily based on single-domain antibodies (Nanobodies), for life science research applications like immunoprecipitation and protein purification.

Explore ChromoTek's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.